Zazzee Naturals sells Liquid MSM eye drops online as an unapproved new drug, FDA says in warning letter.
What happened
FDA reviewed the company's Amazon storefront listings in September 2023 and found Liquid MSM Drops offered for sale in the United States. The listing claims the drops heal damage to the eyes, soften eye membranes, reduce joint pain and lower inflammation, which FDA says makes the product a drug. No FDA-approved application is in effect for it, so FDA calls it an unapproved new drug. No inspection was involved.
What FDA found
The product is a drug because the listing claims it treats eye damage and affects how the body works.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)The product is a "new drug" because it is not generally recognized as safe and effective for the uses claimed.
Section 201(p) of the FD&C Act, 21 U.S.C. 321(p)The company sells the product without an FDA-approved drug application in effect.
Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)Shipping the product across state lines violates the law because it is an unapproved drug.
Section 301(d) of the FD&C Act, 21 U.S.C. 331(d)
What FDA wants
FDA asks the company to write to CDER's Office of Unapproved Drugs and Labeling Compliance within fifteen working days describing the steps taken to fix the violations and prevent them from happening again, with supporting documents. If the company believes the product is not in violation, it should send its reasoning and evidence; if corrections cannot be finished in that time, it should explain why and give a completion date.
Who should pay attention
- online sellers of eye drops and supplement-style products
- brands making drug-like claims for MSM or eye-health products
- marketplaces and retailers listing unapproved drug products
This is a summary. Read the original letter on fda.gov.